Trial intelligence / Profile preview

Nedaplatin vs Cisplatin with Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma

NCT01540136Phase 3Completed

Sponsor
Sun Yat-sen University
Start
Feb 2012
Primary completion
May 2014
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 3 trial of nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Feb 2012; status: completed.

02

Drugs

nedaplatin
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT01540136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01540136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call